The Shwartzman reaction repealed: an interview with Dr. Guido Sireci by Helene F. Rosenberg.
Sireci
Guido
G
D000046:Academic Medical Centers; D000818:Animals; D005699:Galactosylceramides / Q000627:therapeutic use*; D006801:Humans; D007558:Italy; D007694:Killer Cells, Natural / Q000276:immunology*; D008099:Liver / Q000187:drug effects; D051379:Mice; D011971:Receptors, Immunologic / Q000096:biosynthesis; D012790:Shwartzman Phenomenon / Q000276:immunology* / Q000517:prevention & control*; D013997:Time Factors
D005699:Galactosylceramides; C489917:Nktr protein, mouse; D011971:Receptors, Immunologic; C103873:KRN 7000